Page 1 2 ... 30 40 50 ... 200 ... NEXT>>
[ August 28, 2016 | Author: Admin | Views: 91839 | Weather: | Mood: normal]

Related DAL Delta Has 63% Upside, Buckingham Says Airline February Traffic Data: What To Know United Airlines Pre-Merger CEO At Heart Of Board Dispute: Report (Investor’s Business Daily) On CNBC’s Fast Money Halftime Report, Pete Najarian spoke about bullish options activity in Delta Air Lines, Inc. (NYSE: DAL). He said that a trader sold to close 27,000 contracts of the March 48.5 calls and rolled out the position to the April 49 calls for $1.30. The breakeven for the trade is at $50.30 or 5 percent higher from the current price. Najarian decided to follow the trade. He was already long calls in Delta Air Lines but he decided to roll out the position to April. Posted-In: Fast Money Halftime Report Pete NajarianCNBC Options Markets Media © 2016 Benzinga does not provide investment advice. All rights reserved.   Top 5 Promising Stocks To Own Right Now: Telefonica Brasil S.A.(VIV) … Continue reading

[ August 28, 2016 | Author: Admin | Views: 13678 | Weather: | Mood: normal]

Procter & Gamble (PG) gave up its early gains and was trading lower Tuesday, despite reporting better-than-expected third-quarter earnings. Associated Press P&G said it earned 86 cents a share on revenue of $15.76 billion, while analysts were expected 82 cents a share on $15.82 billion. Its guidance for the fourth quarter and full year were in-line with expectations but still call for EPS to fall year over year. Analysts are weighing in on the stock this afternoon. Citis Wendy Nicholson reiterated a Buy rating and raised her price target by 42, to $90, writing that while productivity programs are in full swing sales growth is still elusive: PGs robust cost savings initiatives have led to a 310 bps YoY increase in the companys operating margin YTD in FY16 (300 bps alone in 3Q, despite a 130 bps increase in advertising spending). And, PG sounds confident in its ability to continue … Continue reading

[ August 28, 2016 | Author: Admin | Views: 23924 | Weather: | Mood: normal]

Canaccord Genuity’s Camilo Lyon and Pallav Saini argue that too big a deal is being made about Under Armour’s (UA) new Stephen Curry low-top shoe, which has been ridiculed by, well, everyone: Chef 2 shoes, the Stephen Curry shoes Under Armour The maelstrom around UA’s latest shoe release, the Curry 2 low “Chef Curry”, has reached fever pitch. Social media has lambasted the shoe calling it bland, boring, and suburban (we could go on but you get the point). Even Stephen Colbert got in on the bashing. The negative attention began last Friday a day before the broad launch of the shoe. Since last Friday, the stock has shed 5%. Despite the backlash on the Chef Curry shoe, we believe the weight being placed on its importance has been over-exaggerated Understanding the modest contribution of the Curry Low: The Curry 2 low (which initially launched in February) has never been … Continue reading

[ August 28, 2016 | Author: Admin | Views: 69140 | Weather: | Mood: normal]

Related UAN Mid-Morning Market Update: Markets Mostly Lower; Wal-Mart Lowers Sales Outlook Top 4 Small-Cap Stocks In The Agricultural Chemicals Industry With The Lowest PEG Ratio Energy/Materials – Top 5 Gainers / Losers as of 2:00 pm (Seeking Alpha) Related RFP Resolute Files Racketeering Suit Against Greenpeace in U.S. Federal Court Mid-Afternoon Market Update: Crude Oil Down 2%; KKR Shares Slide Following Q1 Results   Toward the end of trading Tuesday, the Dow traded down 0.50 percent to 17,644.22 while the NASDAQ declined 0.40 percent to 4,829.18. The S&P also fell, dropping 0.42 percent to 2,070.42. Leading and Lagging Sectors On Tuesday, non-cyclical consumer goods & services shares gained by 0.12 percent. In trading on Tuesday, basic materials shares declined by 1.82 percent. Meanwhile, top losers in the sector included CVR Partners LP (NYSE: UAN), down 10 percent, and Resolute Forest Products Inc (NYSE: RFP), down 9 percent. Hot Energy … Continue reading

[ August 27, 2016 | Author: Admin | Views: 75693 | Weather: | Mood: normal]

Shares of Mylan (MYL) have tumbled nearly 20% after the UK-based pharmaceutical company said it would buy Swedish drug maker Meda for $7.2 billion. Citigroup’s Liav Abraham and Nick Nieland explain why they don’t like the deal: MYL-MEDA transaction leaves us scratching our heads: While we acknowledge the potential strategic merits of Mylans proposed acquisition of Meda, announced earlier this evening in conjunction with 4Q15 earnings, we struggle to justify the high price paid for the asset, given Medas low top-line growth profile relative to that of Mylan (c.5% 3-year revenue CAGR, on our estimates). We note that Medas 4Q15 top-line results missed consensus expectations by c.3%, and that the companys 3-year anticipated sales CAGR as set forth in its budget (2016-2018) is 2% vs. Mylans projection of 3%. While we maintain our Buy rating on the name due to supportive valuation, our near-term conviction is diminished, and believe that … Continue reading